Drug
Acotiamide
Acotiamide is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed250%
not_yet_recruiting250%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_4
Comparing Acotiamide and Itopride for the Management of Indigestion
NCT07449689
not_yet_recruitingphase_3
Acotiamide vs Itopride in Postprandial Distress Syndrome
NCT07174297
completednot_applicable
Helicobacter Pylori Eradication in Functional Dyspepsia
NCT04697641
completednot_applicable
Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers
NCT03402984
Clinical Trials (4)
Showing 4 of 4 trials
NCT07449689Phase 4
Comparing Acotiamide and Itopride for the Management of Indigestion
NCT07174297Phase 3
Acotiamide vs Itopride in Postprandial Distress Syndrome
NCT04697641Not Applicable
Helicobacter Pylori Eradication in Functional Dyspepsia
NCT03402984Not Applicable
Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4